Ana Mitrović

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Respiratory Syndrome Coronavirus

High Throughput

Top Venues

Cellular and molecular life sciences : CMLS

Pharmaceuticals (Basel, Switzerland)

Institut Jožef Stefan

University of Ljubljana (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institut Jožef Stefan May 01 2017

Slovenia

Postdoctoral Researcher :: Department of Biotehnology

University of Ljubljana Oct 01 2013 - Mar 31 2017

Slovenia

PhD Student :: Faculty of Pharmacy

Education History

University of Ljubljana Oct 01 2013 - Mar 29 2017

Slovenia

PHD :: Faculty of Pharmacy

Publications

Ana Mitrović, Janja Završnik, Georgy Mikhaylov, Damijan Knez, Urša Pečar Fonović, Petra Matjan Štefin, Miha Butinar, Stanislav Gobec, Boris Turk, Janko Kos
Evaluation of novel cathepsin-X inhibitors in vitro and in vivo and their ability to improve cathepsin-B-directed antitumor therapy. Cellular and molecular life sciences : CMLS 79 (1) (2022)
Janko Kos, Ana Mitrović, Milica Perišić Nanut, Anja Pišlar
Lysosomal peptidases-intriguing roles in cancer progression and neurodegeneration. FEBS open bio 12 (4) (2022)
Ilona Bereczki, Henrietta Papp, Anett Kuczmog, Mónika Madai, Veronika Nagy, Attila Agócs, Gyula Batta, Márton Milánkovits, Eszter Ostorházi, Ana Mitrović, Janko Kos, Áron Zsigmond, István Hajdú, Zsolt Lőrincz, Dávid Bajusz, György Miklós Keserű, Jan Hodek, Jan Weber, Ferenc Jakab, Pál Herczegh, Aniko Borbás
Natural Apocarotenoids and Their Synthetic Glycopeptide Conjugates Inhibit SARS-CoV-2 Replication. Pharmaceuticals (Basel, Switzerland) 14 (11) (2021)
Anja Pišlar, Ana Mitrović, Jerica Sabotič, Urša Pečar Fonović, Milica Perišić Nanut, Tanja Jakoš, Emanuela Senjor, Janko Kos
The role of cysteine peptidases in coronavirus cell entry and replication: The therapeutic potential of cathepsin inhibitors. PLoS pathogens 16 (11) (2020)